[JD Health (6618 HK) Target Price Change]: Strong Execution but Industry Glass Ceiling Remains

⬇ $JD Health(06618)$ - Gross margin continued to deteriorate. The company showed strong ability in OPEX and working capital control; We raise TP from HK$39 to HK$44 and maintain SELL.


Continue reading on Smartkarma:- https://www.smartkarma.com/insights/jd-health-6618-hk-target-price-change-strong-execution-but-industry-glass-ceiling-remains?utm_source=tiger_community

By Shawn Yang, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/shawn-yang-0668bbf2-2f7c-4383-83ed-5389f1dd9587?utm_source=tiger_community

On JD Health (06618):- https://www.smartkarma.com/entities/jd-health-international-inc?utm_source=tiger_community

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment3

  • Top
  • Latest
  • lpb
    ·2023-03-27
    thanks for sharing
    Reply
    Report
  • LSK9092
    ·2023-03-26
    ok
    Reply
    Report
  • longLong
    ·2023-03-26
    [微笑]
    Reply
    Report